Anna Aventı́n

1.9k citations
58 papers · 938 indexed · h-index 20

Anna Aventı́n

58 papers receiving 919 citations

Peers

Anna Aventı́n
Comparison fields: 5 of 60
  • Hematology 495
  • Genetics 317
  • Pathology and Forensic Medicine 232
  • Immunology 147
  • Public Health, Environmental and Occupational Health 185
Replace Barbara Crescenzi with:
Barbara Crescenzi Italy
C Mecucci Italy
Michael Neat United Kingdom
Antonella Bardi Italy
Gianluigi Castoldi Italy
Maitrayee Goswami United States
Ana Rasillo Spain
ER van Wering Netherlands
Pascaline Talmant France
Alfonso García de Coca Spain
Anna Aventı́n relative to Barbara Crescenzi Italy Barbara Crescenzi's profile →
Citations per field
00.5×1.5×
Barbara Crescenzi · 1×
Citations per year

Countries citing papers authored by Anna Aventı́n

Since Specialization
Citations

This map shows the geographic impact of Anna Aventı́n's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Aventı́n with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Aventı́n more than expected).

Fields of papers citing papers by Anna Aventı́n

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Aventı́n. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Aventı́n. The network helps show where Anna Aventı́n may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anna Aventı́n, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Aventı́n Line = papers co-authored together Anna Aventı́n links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201010
2 200917
3 200937
4 20096
5 200820
6 20084
7 20084
8 200720
9 20066
10 200619
11 200435
12 200422
13 20043
14 20034
15 200340
16 199912
17 199716
18 19907
19 199026
20 19893

About Anna Aventı́n

Anna Aventı́n is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 58 papers that have together received 938 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (31 papers), Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers), Chronic Myeloid Leukemia Treatments (12 papers), Acute Lymphoblastic Leukemia research (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Retinoids in leukemia and cellular processes (5 papers). The work is most often cited by research in Hematology (495 citations), Genetics (317 citations) and Pathology and Forensic Medicine (232 citations). Anna Aventı́n has collaborated with scholars based in Spain, Italy and Belgium. Frequent co-authors include Jorge Sierra, Josep Nomdedéu, Salut Brunet, Adriana Lasa, Maria J. Carnicer, Camino Estivill, Cristina Mecucci, Sı́lvia Casas, Herman Van den Berghe and Sakari Knuutila. Their work appears in journals such as Blood, Leukemia, Hematological Oncology, British Journal of Haematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026